Apellis Pharmaceuticals Inc (NQ: APLS )

63.53 USD -0.11 (-0.17%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2021 Add to My Watchlist

Price and Volume

Volume	690,780
Open	62.95
Bid (Size)	58.00 (8)
Ask (Size)	80.00 (2)
Prev. Close	63.64
Today's Range	62.95 - 65.93
52wk Range	26.28 - 73.00
Shares Outstanding	80,496,771
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Apellis Pharmaceuticals to Host Conference Call on August 9, 2021 to Discuss Second Quarter 2021 Financial Results

July 29, 2021

Apellis Announces Closing of Previously Announced Exchanges of Approximately $201.1 Million in Principal Amount of Its 3.500% Convertible Senior Notes Due 2026 for Common Stock

July 26, 2021

Performance

YTD	+16.38%	+16.38%
1 Month	-8.21%	-8.21%
3 Month	+27.83%	+27.83%
6 Month	+37.99%	+37.99%
1 Year	+129.18%	+129.18%

More News

Apellis Announces Agreements to Exchange Approximately $198.6 Million in Principal Amount of Its 3.500% Convertible Senior Notes Due 2026 for Common Stock

July 07, 2021

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 07, 2021

Apellis and Beam Therapeutics Enter Exclusive Research Collaboration to Apply Base Editing to Discover Novel Therapies for Complement-Driven Diseases

June 30, 2021

Cognito Therapeutics Appoints Gerald Chan as Chairman of the Board

July 06, 2021

Implied PTH Analyst Target Price: $185

August 02, 2021

Apellis Pharmaceuticals to Host R&D Day on June 30, 2021

June 23, 2021

Unusual Options Activity Insight: Apellis Pharmaceuticals

July 08, 2021

Analyst Ratings For Apellis Pharmaceuticals

July 08, 2021

10 Biggest Price Target Changes For Thursday

July 08, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.